Advertisement

Serum Bone Gla-Protein Compared to Bone Histomorphometry in Hemodialyzed Patients

  • Sam A. Charhon
  • Pierre D. Delmas
  • Luc Malaval
  • Pascale M. Chavassieux
  • Marie Claire Chapuy
  • Pierre J. Meunier
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 208)

Abstract

Bone gla-protein (BGP), also called osteocalcin1,2, is the most abundant non-collagenous bone protein. BGP is synthesized by the osteoblasts, is concentrated in the bone matrix and also found circulating in the blood. The measurement of BGP in serum by radioimmunoassay3 has proved to be a useful tool for assessing bone turnover in a variety of metabolic or endocrine bone diseascs4–6 and more specifically bone formation in osteoporosis7.

Keywords

Serum Alkaline Phosphatase Bone Formation Rate Serum Biochemical Parameter Serum iPTH Serum Alkaline Phosphatase Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    P.F. Hauschka, J.B. Lian and P.M. Gallop, Direct identifica-tion of the calcium binding amino acid-carboxyglutamate in mineralized tissue, Proc. Natl. Acad. Sci. USA 72: 3925 (1975)CrossRefGoogle Scholar
  2. 2.
    P.A. Price, A.S. Otsuka, J.W. Poser, J. Kristaponis and N. Ramin, Characterization of a gamma-carboxyglutamic acid-containing protein from bone, Proc. Natl. Acad. Sci. USA 73: 1147 (1976)Google Scholar
  3. 3.
    P.A. Price and S.K. Nishimoto, Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma, Proc. Natl. Acad. Sci. USA 77: 2234 (1980)CrossRefGoogle Scholar
  4. 4.
    P.A. Price, J.G. Parthemore and L.J. Deftos, New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone gla-protein in the plasma of normal subjects and patients with bone disease, J. Clin. Invest, 66: 878 (1980)CrossRefGoogle Scholar
  5. 5.
    P. Delmas, H.W. Wahner, K.G. Mann and B.L. Riggs, Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone gla-protein, J. Lab. Clin. Med. 102: 470 (1983)Google Scholar
  6. 6.
    H.H. Malluche, M.C. Faugere, P. Fanti and P.A. Price, Plasma levels of bone gla-protein reflect bone formation in patients on chronic maintenance hemodialysis, Kidney Int. 26: 869 (1984)CrossRefGoogle Scholar
  7. 7.
    J.P. Brown, P.D. Delmas, L. Malaval, C. Edouard, M.C. Chapuy and P.J. Meunier, Serum bone gla-protein: a specific marker for bone formation in post menopausal osteoporosis, Lancet, i: 1091 (1984)Google Scholar
  8. 8.
    S.A. Charhon, Y.F. Berland, M.J. Olmer, E. Delawari, J. Traeger and P.J. Meunier, Effects of parathyroidectomy on bone formation and mineralization in hemodialyzed patients, Kidney Int., 27: 426 (1985)CrossRefGoogle Scholar
  9. 9.
    S.A. Charhon, P.M. Chavassieux, M.C. Chapuy, G.Y. Boivin and P.J. Meunier, Low rate of bone formation with or without histological appearance of osteomalacia in patients with aluminum intoxication, J. Lab. Clin. Med. (1985, in press)Google Scholar
  10. 10.
    P.D. Delmas, D. Stenner, H.W. Wahner, K.G. Mann and B.L. Riggs, Increase in serum bone gamma-carboxyglutamic acid protein with aging in women, J. Clin. Invest. 71: 1316 (1983)CrossRefGoogle Scholar
  11. 11.
    P.D. Delmas, D.M. Wilson, K.G. Mann and B.L. Riggs, Effect of renal function of plasma levels of bone gla-protein, J. Clin. Endocrinol. Metab. 57: 1028 (1983)CrossRefGoogle Scholar
  12. 12.
    H.H. Conaway and C.S. Anast, Double antibody radioimmunoassay for parathyroid hormone, J. Lab. Clin. Med. 83: 129 (1974)Google Scholar
  13. 13.
    Y. Pegon, Dosage de l’aluminium dans les liquides biologiques par absorption atomique sans flamme, Anal. Chim. Acta. 101: 385 (1978)CrossRefGoogle Scholar
  14. 14.
    P.J. Meunier, Bone biopsy in diagnosis of metabolic bone disease, in: “Hormonal control of calcium metabolism” D. V. Cohn, R.V. Talmage and J. Les Matthews, eds, Excerpta Medica, Amsterdam (1980)Google Scholar
  15. 15.
    N.A. Maloney, S.M. Ott, A.C. Alfrey, N.L. Milliner, J.W. Coburn and D.J. Sherrard, Histological quantitation of aluminum in iliac bone from patients with renal failure, J. Lab. Clin. Med. 99: 206 (1982)Google Scholar
  16. 16.
    A.K. Cheung, S.C. Manolagas, B.D. Catherwood, C.A. Mosely Jr, J.A. Mitas III, R.C. Blantz and L.J. Deftos, Determinants of serum 1,25(OH)2D levels in renal disease, Kidney Int. 24: 104 (1983)CrossRefGoogle Scholar
  17. 17.
    S. Epstein, H. Traberg, R. Raja and J. Poser, Serum and dialysate osteocalcin levels in hemodialysis and peritoneal dialysis patients and after renal transplantation, J. Clin. Endocrinol. Metab. 60: 1253 (1985)CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • Sam A. Charhon
    • 1
  • Pierre D. Delmas
    • 1
  • Luc Malaval
    • 1
  • Pascale M. Chavassieux
    • 1
  • Marie Claire Chapuy
    • 1
  • Pierre J. Meunier
    • 1
  1. 1.INSERM U 234Faculté A. CarrelLyonFrance

Personalised recommendations